Kusumoto Shigeru, Kobayashi Yukio, Sekiguchi Naohiro, Tanimoto Kazuki, Onishi Yasushi, Yokota Yukiko, Watanabe Takashi, Maeshima Akiko Miyagi, Ishida Takashi, Inagaki Hiroshi, Matsuno Yoshihiro, Ueda Ryuzo, Tobinai Kensei
Hematology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Am J Surg Pathol. 2005 Aug;29(8):1067-73.
Amplification and translocation of the Bcl-2 gene has been detected in a certain subset of diffuse large B-cell lymphomas (DLBCL). The correlations among Bcl-2 protein expression, gene translocation or amplification, and the molecular signature determined by cDNA array are poorly understood. This study examined 25 cases with de novo nodal DLBCL. Interphase fluorescence in situ hybridization (FISH) analysis was performed to evaluate the Bcl-2 gene using IGH/BCL2 and CEP18 centromere probes (Vysis). When extra Bcl-2 gene signals were observed in each tumor cell and when these signals were in proportion to the extra CEP18 probe signals, we regarded the findings as indicating the presence of an additional chromosome 18; when extra Bcl-2 signals were observed but additional CEP18 signals were not, we regarded the findings as indicating the presence of gene amplification. A panel of 3 antigens (CD10, Bcl-6, and MUM-1) was applied to categorize each case as either a "germinal center B-cell (GCB) phenotype" or a "non-GCB phenotype." Of the 25 cases examined, 8 cases (32%) were classified as "GCB phenotype" and 17 cases (68%) were classified as "non-GCB phenotype." A FISH analysis revealed that t(14;18) was detected in 2 of the 8 cases (25%) with the "GCB phenotype" but in none of the 17 "non-GCB phenotype" cases. Extra Bcl-2 gene signals were detected in 7 of the 25 (28%) cases examined: n = 5 for an additional chromosome 18, n = 1 for gene amplification, and n = 1 for additional chromosome 18 + gene amplification. Extra Bcl-2 gene signals were exclusively detected in DLBCL with the "non-GCB phenotype"; these cases, with the exception of one, stained strongly positive for Bcl-2. The DLBCLs with Bcl-2 protein overexpression were classified into at least two heterogeneous molecular groups, based on the results of the FISH analysis.
在某些弥漫性大B细胞淋巴瘤(DLBCL)亚组中已检测到Bcl-2基因的扩增和易位。Bcl-2蛋白表达、基因易位或扩增与cDNA阵列确定的分子特征之间的相关性尚不清楚。本研究检查了25例初发淋巴结DLBCL病例。采用间期荧光原位杂交(FISH)分析,使用IGH/BCL2和CEP18着丝粒探针(Vysis)评估Bcl-2基因。当在每个肿瘤细胞中观察到额外的Bcl-2基因信号且这些信号与额外的CEP18探针信号成比例时,我们将这些结果视为表明存在额外的18号染色体;当观察到额外的Bcl-2信号但未观察到额外的CEP18信号时,我们将这些结果视为表明存在基因扩增。应用一组3种抗原(CD10、Bcl-6和MUM-1)将每个病例分类为“生发中心B细胞(GCB)表型”或“非GCB表型”。在检查的25例病例中,8例(32%)被分类为“GCB表型”,17例(68%)被分类为“非GCB表型”。FISH分析显示,在8例“GCB表型”病例中有2例(25%)检测到t(14;18),但在17例“非GCB表型”病例中均未检测到。在检查的25例病例中有7例(28%)检测到额外的Bcl-2基因信号:额外的18号染色体为5例,基因扩增为1例,额外的18号染色体+基因扩增为1例。额外的Bcl-2基因信号仅在“非GCB表型”的DLBCL中检测到;除1例病例外,这些病例的Bcl-2染色均为强阳性。根据FISH分析结果,Bcl-2蛋白过表达的DLBCL至少分为两个异质性分子组。